Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christoph U Correll

Showing results (11-20 of 1,040) with videos related to

Pageof 104
Sort By:
The Journal of Clinical Psychiatry|September 15, 2007
Clinical psychopharmacology of pediatric mood stabilizer and antipsychotic treatment, part 1: challenges and developmentsChristoph U Correll
The Journal of Clinical Psychiatry|November 2, 2005
Metabolic side effects of second-generation antipsychotics in children and adolescents: a different story?Christoph U Correll
CNS Spectrums|November 4, 2025
Long-acting injectable antipsychotics for patients with first-episode and early-phase schizophrenia: still not considered often enough - ERRATUMChristoph U Correll
CNS Drugs|July 23, 2025
Strategies for Switching between Oral Postsynaptic Antidopaminergic Antipsychotics in Patients with Schizophrenia: A Systematic ReviewChristoph U Correll
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 15, 2025
Clozapine: past, present and futureChristoph U Correll
CNS Spectrums|April 9, 2008
Acute and long-term adverse effects of antipsychoticsChristoph U Correll
Journal of the American Academy of Child and Adolescent Psychiatry|January 5, 2008
Antipsychotic use in children and adolescents: minimizing adverse effects to maximize outcomesChristoph U Correll
The Journal of Clinical Psychiatry|June 27, 2008
Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescentsChristoph U Correll
International Review of Psychiatry (Abingdon, England)|April 4, 2008
Monitoring and management of antipsychotic-related metabolic and endocrine adverse events in pediatric patientsChristoph U Correll
The Journal of Clinical Psychiatry|May 30, 2008
Antipsychotic polypharmacy, part 1: Shotgun approach or targeted cotreatment?Christoph U Correll
Pageof 104

Showing results (11-20 of 1,040) with videos related to

Sort By:
Pageof 104
The Journal of Clinical Psychiatry|September 15, 2007
Clinical psychopharmacology of pediatric mood stabilizer and antipsychotic treatment, part 1: challenges and developmentsChristoph U Correll
The Journal of Clinical Psychiatry|November 2, 2005
Metabolic side effects of second-generation antipsychotics in children and adolescents: a different story?Christoph U Correll
CNS Spectrums|November 4, 2025
Long-acting injectable antipsychotics for patients with first-episode and early-phase schizophrenia: still not considered often enough - ERRATUMChristoph U Correll
CNS Drugs|July 23, 2025
Strategies for Switching between Oral Postsynaptic Antidopaminergic Antipsychotics in Patients with Schizophrenia: A Systematic ReviewChristoph U Correll
World Psychiatry : Official Journal of the World Psychiatric Association (WPA)|May 15, 2025
Clozapine: past, present and futureChristoph U Correll
CNS Spectrums|April 9, 2008
Acute and long-term adverse effects of antipsychoticsChristoph U Correll
Journal of the American Academy of Child and Adolescent Psychiatry|January 5, 2008
Antipsychotic use in children and adolescents: minimizing adverse effects to maximize outcomesChristoph U Correll
The Journal of Clinical Psychiatry|June 27, 2008
Assessing and maximizing the safety and tolerability of antipsychotics used in the treatment of children and adolescentsChristoph U Correll
International Review of Psychiatry (Abingdon, England)|April 4, 2008
Monitoring and management of antipsychotic-related metabolic and endocrine adverse events in pediatric patientsChristoph U Correll
The Journal of Clinical Psychiatry|May 30, 2008
Antipsychotic polypharmacy, part 1: Shotgun approach or targeted cotreatment?Christoph U Correll
Pageof 104